Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer

NCT01352598 is registered in ClinicalTrials.gov with Mercy Research as lead sponsor.

NCT NCT01352598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01352598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer
Lead sponsor
Mercy Research
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
April 30, 2019
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer